RecruitingNCT06151600
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Studying Charcot-Marie-Tooth disease type 4J
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Elpida Therapeutics SPC
- Principal Investigator
- Souad Messahel, Ph.DElpida Therapeutics SPC
- Enrollment
- 20 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2032
Study locations (3)
- Stanford University, San Francisco, California, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Texas Southwestern, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06151600 on ClinicalTrials.gov